Pigmentation-related phenotypes and risk of prostate cancer

Background:Solar ultraviolet radiation exposure has been inversely related to prostate cancer incidence and mortality, possibly mediated through vitamin D status. Pigmentation-related traits influence endogenous vitamin D synthesis and may alter risk of prostate cancer.Methods:We examined prostate cancer in relation to hair and eye colour, and skin phototype in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort. Incident cancer was diagnosed in 1982 out of 20 863 men. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated from Cox proportional hazards models.Results:Prostate cancer risk did not differ by eye colour or skin phototype. Men with naturally red hair were significantly less likely to develop prostate cancer (HR=0.46, 95% CI 0.24–0.89) than men with light brown hair (reference).Conclusion:The red hair phenotype, which results from polymorphisms in the melanocortin-1-receptor (MC1R) gene, is associated with lower risk of prostate cancer. This pigmentation-related trait may influence prostate cancer development either directly, through genetic effects or regulatory mechanisms related to MC1R, another nearby gene, or other pigmentation genes, or indirectly, through associations with other exposures such as sunlight or vitamin D status.

[1]  J. Fraumeni,et al.  Design, Methods, Participant Characteristics, and Compliance , 1993 .

[2]  J. Carvalho,et al.  Molecular link mechanisms between inflammation and cancer. , 2012, Current pharmaceutical design.

[3]  J. Wikberg,et al.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.

[4]  A. L. Kadekaro,et al.  MC1R and the response of melanocytes to ultraviolet radiation. , 2005, Mutation research.

[5]  Kai Yu,et al.  Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men. , 2011, American journal of epidemiology.

[6]  D. Elder,et al.  Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? , 2010, Cancer.

[7]  M Dosemeci,et al.  Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study , 2002, Occupational and environmental medicine.

[8]  R. Strange,et al.  Ultraviolet radiation: effects on risks of prostate cancer and other internal cancers. , 2005, Mutation research.

[9]  R. Strange,et al.  Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes , 2001, British Journal of Cancer.

[10]  A. Goldstein,et al.  Comprehensive evaluation of allele frequency differences of MC1R variants across populations. , 2006, Human mutation.

[11]  J. Rees.  Vexed by red-headed conundrums. , 2010, The Journal of investigative dermatology.

[12]  T. Fitzpatrick.  The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of dermatology.

[13]  Snæbjörn Pálsson,et al.  Genetic determinants of hair, eye and skin pigmentation in Europeans , 2007, Nature Genetics.

[14]  R. Strange,et al.  Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type. , 2003, Carcinogenesis.

[15]  F. Hu,et al.  A Genome-Wide Association Study Identifies Novel Alleles Associated with Hair Color and Skin Pigmentation , 2008, PLoS genetics.

[16]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[17]  D. Albanes,et al.  The Finnish Cancer Registry as Follow-Up Source of a Large Trial Cohort , 2002, Acta oncologica.

[18]  G. Byrnes,et al.  Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma , 2011, International journal of cancer.

[19]  H. Brenner,et al.  Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk. , 2009, Cancer epidemiology.

[20]  J. Bolognia,et al.  The melanocortin-1 receptor: red hair and beyond. , 2001, Archives of dermatology.

[21]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[22]  N. Hayward,et al.  Melanocortin 1 receptor and risk of cutaneous melanoma: A meta‐analysis and estimates of population burden , 2011, International journal of cancer.

[23]  John P A Ioannidis,et al.  A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. , 2010, Journal of the National Cancer Institute.

[24]  Kai Yu,et al.  Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case–Control Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[25]  J. Barrett,et al.  Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. , 2009, European journal of cancer.

[26]  The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. , 1994, Annals of epidemiology.